Connection

CRAIG LOGSDON to Humans

This is a "connection" page, showing publications CRAIG LOGSDON has written about Humans.
Connection Strength

0.424
  1. Transgenic Expression of PRSS1R122H Sensitizes Mice to Pancreatitis. Gastroenterology. 2020 03; 158(4):1072-1082.e7.
    View in: PubMed
    Score: 0.013
  2. RAGE maintains high levels of NF?B and oncogenic Kras activity in pancreatic cancer. Biochem Biophys Res Commun. 2017 11 04; 493(1):592-597.
    View in: PubMed
    Score: 0.012
  3. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo. Cell Physiol Biochem. 2016; 39(2):740-50.
    View in: PubMed
    Score: 0.011
  4. Acinar Ductal Metaplasia: Yap Fills a Gap. Gastroenterology. 2016 09; 151(3):393-5.
    View in: PubMed
    Score: 0.011
  5. The Significance of Ras Activity in Pancreatic Cancer Initiation. Int J Biol Sci. 2016; 12(3):338-46.
    View in: PubMed
    Score: 0.010
  6. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. PLoS One. 2015; 10(12):e0144969.
    View in: PubMed
    Score: 0.010
  7. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. Am J Physiol Gastrointest Liver Physiol. 2015 Sep 01; 309(5):G283-91.
    View in: PubMed
    Score: 0.010
  8. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014 Sep 15; 74(18):5301-10.
    View in: PubMed
    Score: 0.009
  9. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep. 2014 Mar 19; 4:4410.
    View in: PubMed
    Score: 0.009
  10. Roles for KRAS in pancreatic tumor development and progression. Gastroenterology. 2013 Jun; 144(6):1220-9.
    View in: PubMed
    Score: 0.009
  11. The role of protein synthesis and digestive enzymes in acinar cell injury. Nat Rev Gastroenterol Hepatol. 2013 Jun; 10(6):362-70.
    View in: PubMed
    Score: 0.008
  12. Oncogenic K-Ras requires activation for enhanced activity. Oncogene. 2014 Jan 23; 33(4):532-5.
    View in: PubMed
    Score: 0.008
  13. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Mol Cancer Ther. 2013 May; 12(5):654-62.
    View in: PubMed
    Score: 0.008
  14. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res. 2012 Aug 15; 18(16):4356-64.
    View in: PubMed
    Score: 0.008
  15. An NF-?B pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest. 2012 Apr; 122(4):1519-28.
    View in: PubMed
    Score: 0.008
  16. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut. 2012 Sep; 61(9):1315-22.
    View in: PubMed
    Score: 0.008
  17. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas. 2011 Aug; 40(6):815-22.
    View in: PubMed
    Score: 0.008
  18. Chemoprevention of pancreatic cancer: ready for the clinic? Cancer Prev Res (Phila). 2010 Nov; 3(11):1375-8.
    View in: PubMed
    Score: 0.007
  19. S100P: a novel therapeutic target for cancer. Amino Acids. 2011 Oct; 41(4):893-9.
    View in: PubMed
    Score: 0.007
  20. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol Hepatol. 2009 Nov; 7(11 Suppl):S40-3.
    View in: PubMed
    Score: 0.007
  21. The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS One. 2009 Oct 22; 4(10):e7502.
    View in: PubMed
    Score: 0.007
  22. Ras activity levels control the development of pancreatic diseases. Gastroenterology. 2009 Sep; 137(3):1072-82, 1082.e1-6.
    View in: PubMed
    Score: 0.007
  23. Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. Clin Cancer Res. 2008 Dec 15; 14(24):8143-51.
    View in: PubMed
    Score: 0.006
  24. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008 Oct 01; 68(19):7811-8.
    View in: PubMed
    Score: 0.006
  25. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer. Proteomics. 2008 Aug; 8(15):3051-60.
    View in: PubMed
    Score: 0.006
  26. Endoplasmic reticulum stress and the pancreatic acinar cell. Expert Rev Gastroenterol Hepatol. 2008 Apr; 2(2):249-60.
    View in: PubMed
    Score: 0.006
  27. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008 Feb 01; 68(3):918-26.
    View in: PubMed
    Score: 0.006
  28. RAGE and RAGE ligands in cancer. Curr Mol Med. 2007 Dec; 7(8):777-89.
    View in: PubMed
    Score: 0.006
  29. Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol. 2007 Sep; 23(5):508-14.
    View in: PubMed
    Score: 0.006
  30. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas. 2007 May; 34(4):436-43.
    View in: PubMed
    Score: 0.006
  31. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res. 2007 Mar 15; 67(6):2666-75.
    View in: PubMed
    Score: 0.006
  32. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res. 2005 Aug 01; 11(15):5356-64.
    View in: PubMed
    Score: 0.005
  33. Oligonucleotide-directed microarray gene profiling of pancreatic adenocarcinoma. Methods Mol Med. 2005; 103:175-87.
    View in: PubMed
    Score: 0.005
  34. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology. 2004 Sep; 127(3):957-69.
    View in: PubMed
    Score: 0.005
  35. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res. 2004 Aug 01; 64(15):5338-46.
    View in: PubMed
    Score: 0.005
  36. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003 May 15; 63(10):2649-57.
    View in: PubMed
    Score: 0.004
  37. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol Toxicol. 2002 Dec; 91(6):327-32.
    View in: PubMed
    Score: 0.004
  38. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology. 2001 Dec; 121(6):1380-90.
    View in: PubMed
    Score: 0.004
  39. Phosphatidylinositol 3-kinase and trypsin activation in pancreatitis. J Clin Invest. 2001 Nov; 108(9):1267-8.
    View in: PubMed
    Score: 0.004
  40. Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in?vitro and in?vivo. Pancreatology. 2021 Jan; 21(1):115-123.
    View in: PubMed
    Score: 0.004
  41. Disruption of TGFbeta signaling pathways in human pancreatic cancer cells. Ann Surg. 2000 Jul; 232(1):73-80.
    View in: PubMed
    Score: 0.004
  42. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. J Biol Chem. 2020 02 21; 295(8):2348-2358.
    View in: PubMed
    Score: 0.003
  43. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters. Cell Rep. 2019 12 10; 29(11):3448-3459.e6.
    View in: PubMed
    Score: 0.003
  44. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Rep. 2019 10 22; 29(4):889-903.e10.
    View in: PubMed
    Score: 0.003
  45. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet. Gastroenterology. 2019 11; 157(5):1413-1428.e11.
    View in: PubMed
    Score: 0.003
  46. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach. Int J Nanomedicine. 2019; 14:3111-3128.
    View in: PubMed
    Score: 0.003
  47. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Sci Transl Med. 2018 10 24; 10(464).
    View in: PubMed
    Score: 0.003
  48. The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Pancreas. 2018 May/Jun; 47(5):516-525.
    View in: PubMed
    Score: 0.003
  49. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via?Integrin Signaling. Gastroenterology. 2018 04; 154(5):1524-1537.e6.
    View in: PubMed
    Score: 0.003
  50. The immune system in cancer metastasis: friend or foe? J Immunother Cancer. 2017 10 17; 5(1):79.
    View in: PubMed
    Score: 0.003
  51. Adenoviral-mediated gene transfer of a constitutively active retinoblastoma gene inhibits human pancreatic tumor cell proliferation. Surgery. 1997 Aug; 122(2):428-33; discussion 433-4.
    View in: PubMed
    Score: 0.003
  52. Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines. Gastroenterology. 1997 Mar; 112(3):952-9.
    View in: PubMed
    Score: 0.003
  53. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Res. 2017 05 15; 77(10):2647-2660.
    View in: PubMed
    Score: 0.003
  54. The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury. PLoS One. 2016; 11(10):e0165485.
    View in: PubMed
    Score: 0.003
  55. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. Cancer Epidemiol. 2016 06; 42:115-23.
    View in: PubMed
    Score: 0.003
  56. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization. Mol Pharmacol. 1995 Sep; 48(3):477-85.
    View in: PubMed
    Score: 0.003
  57. Pancreatic duct cell cultures: there is more to ducts than salty water. Gastroenterology. 1995 Sep; 109(3):1005-9.
    View in: PubMed
    Score: 0.003
  58. Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. Sci Rep. 2015 Aug 20; 5:13347.
    View in: PubMed
    Score: 0.003
  59. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice. Mol Cancer Ther. 2015 Apr; 14(4):941-51.
    View in: PubMed
    Score: 0.002
  60. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2014 Nov; 13(11):2583-94.
    View in: PubMed
    Score: 0.002
  61. Preliminary evaluation of 1'-[(18)F]fluoroethyl-?-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts. Nucl Med Biol. 2014 Nov-Dec; 41(10):833-40.
    View in: PubMed
    Score: 0.002
  62. Convergence of nanotechnology and cancer prevention: are we there yet? Cancer Prev Res (Phila). 2014 Oct; 7(10):973-92.
    View in: PubMed
    Score: 0.002
  63. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1. J Biol Chem. 2014 Feb 14; 289(7):4009-17.
    View in: PubMed
    Score: 0.002
  64. Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I. Cancer Prev Res (Phila). 2013 Oct; 6(10):1046-55.
    View in: PubMed
    Score: 0.002
  65. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013 Sep; 5(9):1322-34.
    View in: PubMed
    Score: 0.002
  66. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res. 2013 Jul 01; 73(13):3927-37.
    View in: PubMed
    Score: 0.002
  67. Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor. Pancreas. 2013 Apr; 42(3):467-74.
    View in: PubMed
    Score: 0.002
  68. Pancreatic cancer-associated Cathepsin E as a drug activator. J Control Release. 2013 May 10; 167(3):221-7.
    View in: PubMed
    Score: 0.002
  69. Study human pancreatic cancer in mice: how close are they? Biochim Biophys Acta. 2013 Jan; 1835(1):110-8.
    View in: PubMed
    Score: 0.002
  70. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in ? cells and mice. Gastroenterology. 2012 Dec; 143(6):1510-1517.e1.
    View in: PubMed
    Score: 0.002
  71. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One. 2012; 7(8):e42699.
    View in: PubMed
    Score: 0.002
  72. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Mol Cancer Res. 2012 Sep; 10(9):1147-57.
    View in: PubMed
    Score: 0.002
  73. Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. PLoS One. 2012; 7(7):e40420.
    View in: PubMed
    Score: 0.002
  74. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. J Hematol Oncol. 2012 Apr 04; 5:15.
    View in: PubMed
    Score: 0.002
  75. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2012 Feb 01; 72(3):655-65.
    View in: PubMed
    Score: 0.002
  76. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012 Feb; 61(2):172-8.
    View in: PubMed
    Score: 0.002
  77. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011 Nov 15; 17(22):7015-23.
    View in: PubMed
    Score: 0.002
  78. Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe. Mol Biosyst. 2011 Dec; 7(12):3207-3213.
    View in: PubMed
    Score: 0.002
  79. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol. 2012 Jul; 19 Suppl 3:S395-403.
    View in: PubMed
    Score: 0.002
  80. The induction of S100p expression by the Prostaglandin E2 (PGE2)/EP4 receptor signaling pathway in colon cancer cells. Cancer Biol Ther. 2010 Nov 15; 10(10):1056-66.
    View in: PubMed
    Score: 0.002
  81. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer. 2011 Feb 15; 117(4):734-43.
    View in: PubMed
    Score: 0.002
  82. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010 Mar 01; 16(5):1423-30.
    View in: PubMed
    Score: 0.002
  83. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res. 2009 Oct 01; 15(19):5993-6001.
    View in: PubMed
    Score: 0.002
  84. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009 Jul 15; 69(14):5820-8.
    View in: PubMed
    Score: 0.002
  85. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell. 2009 Mar 03; 15(3):207-19.
    View in: PubMed
    Score: 0.002
  86. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res. 2009 Feb 01; 69(3):1063-70.
    View in: PubMed
    Score: 0.002
  87. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008 Aug 01; 68(15):6100-8.
    View in: PubMed
    Score: 0.002
  88. Direct versus indirect action of cholecystokinin on human pancreatic acinar cells: is it time for a judgment after a century of trial? Gastroenterology. 2008 Aug; 135(2):357-60.
    View in: PubMed
    Score: 0.002
  89. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem. 1988 Feb 25; 263(6):2581-4.
    View in: PubMed
    Score: 0.001
  90. Gastrin in pancreatic tumors transfected with CCK-B receptors. Gastroenterology. 1998 Feb; 114(2):419.
    View in: PubMed
    Score: 0.001
  91. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst. 2008 Jan 16; 100(2):109-20.
    View in: PubMed
    Score: 0.001
  92. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A. 2007 Nov 20; 104(47):18636-41.
    View in: PubMed
    Score: 0.001
  93. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum. 2007 Aug; 50(8):1230-40.
    View in: PubMed
    Score: 0.001
  94. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res. 2007 Jul 15; 13(14):4209-17.
    View in: PubMed
    Score: 0.001
  95. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Mol Cancer Ther. 2006 Sep; 5(9):2251-60.
    View in: PubMed
    Score: 0.001
  96. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Res. 2006 Jan 15; 66(2):898-906.
    View in: PubMed
    Score: 0.001
  97. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor. J Biol Chem. 2005 Mar 18; 280(11):10664-74.
    View in: PubMed
    Score: 0.001
  98. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas. 2004 Nov; 29(4):254-63.
    View in: PubMed
    Score: 0.001
  99. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery. 2004 Sep; 136(3):708-15.
    View in: PubMed
    Score: 0.001
  100. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res. 2004 Aug 01; 64(15):5504-10.
    View in: PubMed
    Score: 0.001
  101. Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. Am J Pathol. 2003 Nov; 163(5):1985-95.
    View in: PubMed
    Score: 0.001
  102. Dominant negative Rab3D inhibits amylase release from mouse pancreatic acini. J Biol Chem. 2002 May 17; 277(20):18002-9.
    View in: PubMed
    Score: 0.001
  103. Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancer. Int J Gastrointest Cancer. 2002; 31(1-3):79-88.
    View in: PubMed
    Score: 0.001
  104. Recombinant adenoviral expression of dominant-negative Ras N17 blocking radiation-induced activation of mitogen-activated protein kinase pathway. Methods Enzymol. 2001; 333:28-37.
    View in: PubMed
    Score: 0.001
  105. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell. 1999 Aug; 10(8):2493-506.
    View in: PubMed
    Score: 0.001
  106. Down-regulation of the G-proteins Gq alpha and G11 alpha by transfected human M3 muscarinic acetylcholine receptors in Chinese hamster ovary cells is independent of receptor down-regulation. Biochem J. 1995 Sep 01; 310 ( Pt 2):559-63.
    View in: PubMed
    Score: 0.001
  107. Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine resides are required for agonist-induced receptor down-regulation. Mol Pharmacol. 1993 Dec; 44(6):1158-64.
    View in: PubMed
    Score: 0.001
  108. Identification and cloning of GP-3 from rat pancreatic acinar zymogen granules as a glycosylated membrane-associated lipase. J Biol Chem. 1993 May 15; 268(14):10303-11.
    View in: PubMed
    Score: 0.001
  109. Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A. 1991 Jan 15; 88(2):429-33.
    View in: PubMed
    Score: 0.000
  110. Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels. Diabetes. 1989 Feb; 38(2):182-7.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.